Sectors
ACET
Adicet Bio, Inc.
8.72
2 x 6.38
2 x 11.21
bid
ask
-
0.34
3.75%
02:05 PM
timesize
| Ytd | 3.56% | |
| 1y | -24.31% |
8.62
day range
9.06
6.01
52 week range
17.44
| Open | 8.92 | Prev Close | 9.06 | Low | 8.62 | High | 9.06 | Mkt Cap | 81.63M |
| Vol | 82.75K | Avg Vol | 90.81K | EPS | -10.42 | P/E | N/A | Forward P/E | -0.69 |
| Beta | 1.60 | Short Ratio | 7.04 | Inst. Own | 76.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 8.60 | 200-d Avg | 8.10 | 1yr Est | 6.40 |
| Income Statement | |||
| Operating Expenses | 22.30M | ||
| Research and Development Expense | 18.45M | ||
| Selling, General and Administrative Expense | 3.85M | ||
| Operating Income | -22.30M | ||
| Interest Expense | 22.00K | ||
| Income Tax Expense | 143.00K | ||
| Net Income | -21.36M | ||
| Net Income Common Stock | -21.36M | ||
| Net Income Common Stock (USD) | -21.36M | ||
| Consolidated Income | -21.36M | ||
| Earnings per Basic Share | -1.99 | ||
| Earnings per Basic Share (USD) | -1.99 | ||
| Earnings per Diluted Share | -1.99 | ||
| Earning Before Interest & Taxes (EBIT) | -21.19M | ||
| Earning Before Interest & Taxes (USD) | -21.19M | ||
| Weighted Average Shares | 10.75M | ||
| Weighted Average Shares Diluted | 10.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 36.00M | ||
| Cash and Equivalents (USD) | 36.00M | ||
| Investments | 85.06M | ||
| Investments Current | 85.06M | ||
| Current Assets | 120.76M | ||
| Property, Plant & Equipment Net | 24.45M | ||
| Total Assets | 148.17M | ||
| Debt Current | 2.83M | ||
| Total Debt | 12.85M | ||
| Current Liabilities | 18.00M | ||
| Debt Non-Current | 10.03M | ||
| Total Liabilities | 28.03M | ||
| Accumulated Retained Earnings (Deficit) | -656.30M | ||
| Accumulated Other Comprehensive Income | -105.00K | ||
| Shareholders Equity | 120.14M | ||
| Shareholders Equity (USD) | 120.14M | ||
| Assets Non-Current | 27.40M | ||
| Total Debt (USD) | 12.85M | ||
| Liabilities Non-Current | 10.03M | ||
| Trade and Non-Trade Payables | 3.59M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.95M | ||
| Net Cash Flow from Financing | 58.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.11M | ||
| Capital Expenditure | -202.00K | ||
| Issuance (Purchase) of Equity Shares | 83.00K | ||
| Net Cash Flow from Investing | 16.65M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 16.85M | ||
| Net Cash Flow from Operations | -19.82M | ||
| Share Based Compensation | 1.44M | ||